286 related articles for article (PubMed ID: 32253240)
21. PD-L1-driven tolerance protects neurogenin3-induced islet neogenesis to reverse established type 1 diabetes in NOD mice.
Li R; Lee J; Kim MS; Liu V; Moulik M; Li H; Yi Q; Xie A; Chen W; Yang L; Li Y; Tsai TH; Oka K; Chan L; Yechoor V
Diabetes; 2015 Feb; 64(2):529-40. PubMed ID: 25332429
[TBL] [Abstract][Full Text] [Related]
22. FasL microgels induce immune acceptance of islet allografts in nonhuman primates.
Lei J; Coronel MM; Yolcu ES; Deng H; Grimany-Nuno O; Hunckler MD; Ulker V; Yang Z; Lee KM; Zhang A; Luo H; Peters CW; Zou Z; Chen T; Wang Z; McCoy CS; Rosales IA; Markmann JF; Shirwan H; García AJ
Sci Adv; 2022 May; 8(19):eabm9881. PubMed ID: 35559682
[TBL] [Abstract][Full Text] [Related]
23. Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition.
Stepkowski SM; Phan T; Zhang H; Bilinski S; Kloc M; Qi Y; Katz SM; Rutzky LP
Transplantation; 2006 Dec; 82(12):1756-63. PubMed ID: 17198272
[TBL] [Abstract][Full Text] [Related]
24. Engineering pancreatic islets with a novel form of thrombomodulin protein to overcome early graft loss triggered by instant blood-mediated inflammatory reaction.
Turan A; Zhang L; Tarique M; Ulker V; Arguc FN; Badal D; Yolcu ES; Shirwan H
Am J Transplant; 2023 May; 23(5):619-628. PubMed ID: 36863480
[TBL] [Abstract][Full Text] [Related]
25. Immunoprotection and Functional Improvement of Allogeneic Islets in Diabetic Mice, Using a Stable Indoleamine 2,3-Dioxygenase Producing Scaffold.
Hosseini-Tabatabaei A; Jalili RB; Khosravi-Maharlooei M; Hartwell R; Kilani RT; Zhang Y; Ghahary A
Transplantation; 2015 Jul; 99(7):1341-8. PubMed ID: 25769070
[TBL] [Abstract][Full Text] [Related]
26. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.
Li H; Colson YL; Ildstad ST
Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege.
Woodward KB; Zhao H; Shrestha P; Batra L; Tan M; Grimany-Nuno O; Bandura-Morgan L; Askenasy N; Shirwan H; Yolcu ES
Am J Transplant; 2020 May; 20(5):1285-1295. PubMed ID: 31850658
[TBL] [Abstract][Full Text] [Related]
28. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
[TBL] [Abstract][Full Text] [Related]
29. Low-dose rapamycin unmasks the protective potential of targeting intragraft NF-κB for islet transplants.
Zammit NW; Tan BM; Walters SN; Liuwantara D; Villanueva JE; Malle EK; Grey ST
Cell Transplant; 2013; 22(12):2355-66. PubMed ID: 23127588
[TBL] [Abstract][Full Text] [Related]
30. Induction of tolerance and prolongation of islet allograft survival by syngeneic hematopoietic stem cell transplantation in mice.
Yang SF; Xue WJ; Lu WH; Xie LY; Yin AP; Zheng J; Sun JP; Li Y
Transpl Immunol; 2015 Oct; 33(2):130-9. PubMed ID: 26311302
[TBL] [Abstract][Full Text] [Related]
31. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.
Nishihara M; Gotoh M; Ohzato H; Ohta Y; Luo Z; Dono K; Umeshita K; Sakon M; Monden M; Yagita H; Okumura K; Miyasaka M
Transplantation; 1997 Oct; 64(7):965-70. PubMed ID: 9381542
[TBL] [Abstract][Full Text] [Related]
32. B10 cells play a role in the immune modulation of pro- and anti-inflammatory immune responses in mouse islet allograft rejection.
Qin Y; Zhang M; Jiang RM; Wu Q; Xu XY; Chen H; Yang T
Cell Immunol; 2016 Dec; 310():184-192. PubMed ID: 27667759
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy via PD-L1-presenting biomaterials leads to long-term islet graft survival.
Coronel MM; Martin KE; Hunckler MD; Barber G; O'Neill EB; Medina JD; Opri E; McClain CA; Batra L; Weaver JD; Lim HS; Qiu P; Botchwey EA; Yolcu ES; Shirwan H; García AJ
Sci Adv; 2020 Aug; 6(35):eaba5573. PubMed ID: 32923626
[TBL] [Abstract][Full Text] [Related]
34. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
Fiedor P; Jin MX; Hardy MA; Oluwole SF
Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
[TBL] [Abstract][Full Text] [Related]
35. PD-L1 Deficiency within Islets Reduces Allograft Survival in Mice.
Ma D; Duan W; Li Y; Wang Z; Li S; Gong N; Chen G; Chen Z; Wan C; Yang J
PLoS One; 2016; 11(3):e0152087. PubMed ID: 26990974
[TBL] [Abstract][Full Text] [Related]
36. Biopatterned CTLA4/Fc Matrices Facilitate Local Immunomodulation, Engraftment, and Glucose Homeostasis After Pancreatic Islet Transplantation.
Zhang W; Gorantla VS; Campbell PG; Li Y; Yang Y; Komatsu C; Weiss LE; Zheng XX; Solari MG
Diabetes; 2016 Dec; 65(12):3660-3666. PubMed ID: 27650855
[TBL] [Abstract][Full Text] [Related]
37. Immuno-protective vesicle-crosslinked hydrogel for allogenic transplantation.
Wang Y; Huang R; Lu Y; Liu M; Mo R
Nat Commun; 2024 Jun; 15(1):5176. PubMed ID: 38890279
[TBL] [Abstract][Full Text] [Related]
38. Engineered immunomodulatory accessory cells improve experimental allogeneic islet transplantation without immunosuppression.
Wang X; Wang K; Yu M; Velluto D; Hong X; Wang B; Chiu A; Melero-Martin JM; Tomei AA; Ma M
Sci Adv; 2022 Jul; 8(29):eabn0071. PubMed ID: 35867788
[TBL] [Abstract][Full Text] [Related]
39. Differential Impact of T-bet and IFNγ on Pancreatic Islet Allograft Rejection.
Besançon A; Demir Z; Goncalves T; Valette F; Panafieu E; Chatenoud L; You S
Transplantation; 2018 Sep; 102(9):1496-1504. PubMed ID: 29757902
[TBL] [Abstract][Full Text] [Related]
40. Prolonged allogeneic islet graft survival by protoporphyrins.
Pileggi A; Molano RD; Berney T; Ichii H; San Jose S; Zahr E; Poggioli R; Linetsky E; Ricordi C; Inverardi L
Cell Transplant; 2005; 14(2-3):85-96. PubMed ID: 15881418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
